Huawei Technologies Co., Ltd.
A story from the Pharmaceutical industry illustrates the growing complexity of supply chain management in an era of increased governance and public scrutiny. It also raises an opportunity for suppliers to consider new terms and conditions that might address the needs and concerns of their customers.
This content is only available to paid members.Register Now or sign in
Please sign in or register to post on this forum